Research and Markets: A Product and Pipeline Analysis of the Global Hepatitis C Virus (HCV) Antiviral Market

Research and Markets (http://www.researchandmarkets.com/research/hp6qk5/a_product_and) has announced the addition of the "A Product and Pipeline Analysis of the Global Hepatitis C Virus (HCV) Antiviral Market" report to their offering.

This research service focuses on antiviral therapeutics for the treatment of the hepatitis C virus (HCV). A global product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HCV.

Segmentation by drug class is provided, along with supporting information such as clinical trial timelines and results, key market developments, historical and projected launch timelines, and epidemiology.

The information contained in this research was derived from published sources, including disease organizations; public health organizations; company publications including annual reports, SEC filings, and press releases; government public sources; and articles in scientific journals.

Key Topics Covered:

1. Executive Summary

2. Methodology and Scope

3. Introduction

4. Competitive Analysis

5. Conclusions and Recommendations

6. Appendix

7. The Company Story

Companies Mentioned

• Abbvie
• Achillion
• Alios
• AllaChem
• B&C Biopharm
• BMS
• Biotron
• Enanta
• Gilead
• Inovio
• J&J
• Merck
• Microbiotix
• Roche
• Romark Laboratories
• Spring Bank
• TiaGen
• Vertex
• ViroLogik

For more information visit http://www.researchandmarkets.com/research/hp6qk5/a_product_and